Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-006263-23Phase 4Terminated
Phase 4, single-arm trial of oseltamivir in influenza, Influenza A infection and influenza B, sponsored by Roche. Primary endpoints: Time to return to normal health status and Time to return to normal levels of activity. Started Jan 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-006263-23.